NCT02808104 - Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

March 28, 2017

Study Completion Date

March 28, 2017

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

mazindol

Trial Locations (7)

CNS Healthcare, Jacksonville

Clinical Neuroscience Solutions, Memphis

Rochester Center for Behavorial Medicine, Rochester Hills

Midwest Research Group / St. Charles Psychiatric Associates, Saint Charles

Memorial Park Psychiatry / Bayou City Research, Houston

AVIDA Clinic, Newport Beach

South Shore Psychiatric Services, Marshfield